Tumor Mutational Burden and PD-L1 Expression in Hematologic Malignancies

被引：1
|
作者：
Thomas, Sean D.
Jeong, Ah-Reum
Sakowski, Patrick J.
Sokol, Ethan S.
Kurzrock, Razelle
Goodman, Aaron M.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134375
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Predictive value of tumor mutational burden for PD-1/PD-L1 inhibitors in NSCLC: A meta-analysis
    Li, Wenjie
    Zhao, Yanjun
    Zhang, Hongjun
    Zheng, Wenying
    Wang, Ruixuan
    Gu, Xing
    MEDICINE, 2023, 102 (40) : E34990
  • [22] Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond
    Zhu, Jason
    Armstrong, Andrew J.
    Friedlander, Terence W.
    Kim, Won
    Pal, Sumanta K.
    George, Daniel J.
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [23] Mutational Analysis in Pulmonary Adenocarcinomas with PD-L1 Expression
    Setoodeh, Reza
    Walts, Ann
    Makhoul, Elias
    Marchevsky, Alberto
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1816 - 1817
  • [24] Mutational Analysis in Pulmonary Adenocarcinomas with PD-L1 Expression
    Setoodeh, Reza
    Walts, Ann
    Makhoul, Elias
    Marchevsky, Alberto
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1816 - 1817
  • [25] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [26] Quantification of PD-L1 expression and tumor mutational burden in biologically distinct advanced pancreatic cancers responding to pembrolizumab: case reports
    Li, Kevin Y.
    Lowy, Andrew M.
    Fanta, Paul
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [27] Associations of genomic alteration, tumor mutational burden with PD-L1 expression and response to immune checkpoint inhibitors in Chinese lung patients
    Hu, Jing
    Li, Bixun
    Zou, Bing
    Wang, Senming
    Qiu, Ye
    Yan, Maolin
    Zeng, Zhiming
    Yang, Han
    Guan, Yan
    Zhang, Lei
    Chen, Wei
    Zhang, Yuan
    Mei, Lei
    Dong, Xiaowei
    Yao, Ming
    Wang, Kai
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Tumor Mutational Burden, Immunoscore and PD-L1 Expression in Patients with Epstein-Barr virus-associated Gastric Cancer
    He, Lu
    MODERN PATHOLOGY, 2019, 32
  • [29] Association of BRCA-mutant pancreatic cancer with high tumor mutational burden (TMB) and higher PD-L1 expression.
    Seeber, Andreas
    Puccini, Alberto
    Xiu, Joanne
    Goldberg, Richard M.
    Grothey, Axel
    Shields, Anthony Frank
    Salem, Mohamed E.
    Battaglin, Francesca
    El-Deiry, Wafik S.
    Tokunaga, Ryuma
    Philip, Philip Agop
    Marshall, John
    Kocher, Florian
    Hall, Michael J.
    Korn, Wolfgang Michael
    Lenz, Heinz-Josef
    Spizzo, Gilbert
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients
    Nikanjam, Mina
    Arguello, David
    Gatalica, Zoran
    Swensen, Jeff
    Barkauskas, Donald A.
    Kurzrock, Razelle
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (11) : 3087 - 3097
12345